Recognition and Management of Delirium in the Neonatal Intensive Care Unit: Case Series From a Single-Center Level IV

Stacey Dornette1, Stephen Deptola2, Brianna Hemmann2

  • 1Division of Neonatology and Pulmonary Biology, Cincinnati Children's Hospital, Cincinnati, OH, USA.

PubMed

Insights

Delirium in neonates is often missed. This study explored quetiapine as a treatment for delirium in medically complex infants, offering guidance for future management.

Area of Science:

  • Neonatal medicine
  • Pediatric neurology
  • Pharmacology

Background:

  • Delirium in neonates and children is frequently underdiagnosed due to challenges in behavioral assessment and lack of awareness.
  • Distinctive symptoms and limited data hinder effective pharmacologic treatment strategies for pediatric delirium.
  • There is a growing recognition of delirium in neonates, necessitating evidence-based treatment guidelines.

Purpose of the Study:

  • To present the clinical experience of using quetiapine for treating delirium in medically complex neonates.
  • To propose a monitoring and treatment approach for neonatal and infant delirium based on literature and expert opinion.

Main Methods:

  • Retrospective single-center case series involving 9 medically complex neonates.
  • Extensive literature review on neonatal delirium and its management.
  • Incorporation of expert opinion and institutional experience.

Main Results:

  • Experience using quetiapine in 9 medically complex neonates with delirium is detailed.
  • The study provides a foundation for a proposed approach to managing neonatal delirium.

Conclusions:

  • Quetiapine was used to treat delirium in a small cohort of medically complex neonates.
  • The findings support the need for further research and development of standardized approaches for neonatal delirium management.